Enhance the management mechanism and effectively implement GMP.

Release date:

2021-07-22

From July 12 to 14, 2021, Baihui Pharmaceutical invited the expert team from the China Food and Drug Administration Information Network to conduct an audit of the company’s production and quality management systems.

From July 12 to 14, 2021, Baihui Pharmaceutical invited the expert team from the China Food and Drug Administration Information Network to audit the company’s production and quality management systems.

Auditing is a self-certification process for pharmaceutical companies in implementing GMP (Good Manufacturing Practice, the "Pharmaceutical Production Quality Management Guidelines") and establishing a robust quality management system. It is an enterprise practice mandated by GMP regulations and must be carried out to assess whether the company consistently meets all GMP requirements. Through GMP auditing, Baihui Pharmaceutical can enhance its self-improvement management mechanisms, encouraging each functional department to implement GMP more effectively. This ensures that Baihui Pharmaceutical’s production quality management system remains consistently effective while continuously evolving and refining itself over time.

Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Party Committee organized and convened a special democratic life meeting on Party history study and education.

Leaders from the Guangxi Institute for Food and Drug Control visit Baihui Pharmaceutical for technical exchange.